Improving Depressive Symptoms of Post-stroke Depression Using the Shugan Jieyu Capsule: A Resting-State Functional Magnetic Resonance Imaging Study

• Published in: Frontiers in neurology Vol. 13; p. 860290
• Main Authors: Yao, Guanqun, Zhang, Xiaoqian, Li, Jing, Liu, Sha, Li, Xinrong, Liu, Pozi, Xu, Yong
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 14.04.2022
• Subjects: depressive symptoms; fractional amplitude of low-frequency fluctuation; functional magnetic resonance imaging; Neurology; post-stroke depression; regional homogeneity; Shugan Jieyu capsule; fractional amplitude of low-frequency fluctuation; post-stroke depression; regional homogeneity; depressive symptoms; functional magnetic resonance imaging; Shugan Jieyu capsule
• ISSN: 1664-2295; 1664-2295
• DOI: 10.3389/fneur.2022.860290

Regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuation (fALFF) were used to detect the neuroimaging mechanism of Shugan Jieyu Capsule (SG) in ameliorating depression of post-stroke depression (PSD) patients. Fifteen PSD patients took SG for 8 weeks, completed the 24-item Hamilton Depression Scale (HAMD) assessment at the baseline and 8 weeks later, and underwent functional magnetic resonance imaging (fMRI) scanning. Twenty-one healthy controls (HCs) underwent these assessments at the baseline. We found that SG improved depression of PSD patients, in which ReHo values decreased in the left calcarine sulcus (CAL.L) and increased in the left superior frontal gyrus (SFG.L) of PSD patients at the baseline. The fALFF values of the left inferior parietal cortex (IPL.L) decreased in PSD patients at the baseline. Abnormal functional activities in the brain regions were reversed to normal levels after the administration of SG for 8 weeks. Receiver operating characteristic (ROC) analysis found that the changes in three altered brain regions could be used to differentiate PSD patients at the baseline and HCs. Average signal values of altered regions were related to depression in all subjects at the baseline. Our results suggest that SG may ameliorate depression of PSD patients by affecting brain region activity and local synchronization.